Herceptin Hylecta is usually given by a health care provider in a hospital or clinic. You will not store it at home. Side Effects What are the most common side effects of Herceptin Hylecta? The most common side effects of Herceptin Hylecta are listed below. Tell your health care provider ...
Herceptin Hylecta (Trastuzumab and Hyaluronidase-oysk Injection, for Subcutaneous Use) may treat, side effects, dosage, drug interactions, warnings, patient labeling, reviews, and related medications including drug comparison and health resources.
SIDE EFFECTS SEEN MOST OFTEN The most common side effects seen in treatment of adjuvant breast cancer with HERCEPTIN HYLECTA were tiredness, joint pain, diarrhea, injection site reaction, upper respiratory tract infection, rash, muscle pain, nausea, headache, swelling, flushing, fever, cough, and...
SIDE EFFECTS SEEN MOST OFTEN The most common side effects seen in treatment of adjuvant breast cancer with Herceptin HYLECTA were tiredness, joint pain, diarrhea, injection site reaction, upper respiratory tract infection, rash, muscle pain, nausea, headache, swelling, flushing, fever, cough, and...
Permanently discontinue HERCEPTIN HYLECTA in patients who experience anaphylaxis or severe hypersensitivity reactions. (5.5) Adverse Reactions/Side Effects Adjuvant Breast Cancer Most common adverse reactions (≥10%) for HERCEPTIN HYLECTA are fatigue, arthralgia, diarrhea, injection site reaction, upper ...
Find information on Trastuzumab/hyaluronidase (Herceptin Hylecta) in Davis’s Drug Guide including dosage, side effects, interactions, nursing implications, mechanism of action, half life, administration, and more. Davis Drug Guide PDF.
Herceptin Hylecta Dosage Herceptin Hylecta Dosage Generic name:TRASTUZUMAB 600mg in 5mL, HYALURONIDASE(HUMAN RECOMBINANT) 10000U in 5mL Dosage form:injection, solution Drug class:HER2 inhibitors Medically reviewedby Drugs.com. Last updated on Nov 21, 2024. ...
Herceptin (trastuzumab), Herceptin Hylecta (trastuzumab and hyaluronidase-oysk), Hercessi (trastuzumab-strf), Kanjinti (trastuzumab-anns), Ontruzant (trastuzumab-dttb), and Trazimera (trastuzumab-qyyp) are more costly to Aetna than other Anti-HER2 Monoclonal Antibodies. There is a lack of ...
Consider the developmental and health benefits of breastfeeding along with the mother’s clinical need for HERCEPTIN HYLECTA treatment and any potential adverse effects on the breastfed child from HERCEPTIN HYLECTA or from the underlying maternal condition ...
HERCEPTIN HYLECTA alone is approved for the treatment of HER2-positive breast cancer in patients who have received one or more chemotherapy courses for metastatic disease Patients are selected for therapy based on an FDA-approved test for trastuzumab. Possible Serious Side Effects With HERCEPTIN Not ...